Johan von Heijne new CEO of Biolin Scientific


This information is disclosed in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the exchange rules.

Johan von Heijne has been appointed as the new CEO of Ratos's subsidiary Biolin Scientific with effect from 1 February 2013. Johan von Heijne has long and sound experience within the biotechnology sector.

Johan von Heijne, born 1961, will join Biolin Scientific from GE Healthcare Life Sciences where he has been General Manager of the Research Products business area since 2008. In this role Johan was responsible for a product area with annual sales of USD 500m worldwide and manager for more than 100 employees in several countries. He has previously held leading positions within Biacore and Radi Medical, among others.

The Chairman of Biolin's Board, Peter Ehrenheim, comments: "Johan von Heijne has broad experience within Life Sciences Tools, and a documented ability to get things done, most recently at General Electric. His broad experience and strategic talents make him a highly suitable CEO for Biolin Scientific. We on the Board are convinced that Johan, together with other members of the management team, can develop Biolin Scientific into a strong and expansive company."

Johan von Heijne will take up his position on 1 February 2013 and succeed Jan Wahlström.

Biolin Scientific develops, manufactures and markets analytical instruments for research, development, quality control and dental diagnostics. The company is specialised in surface measurement with applications within Life Sciences but also within material science and nanotechnology. The company also holds a very strong position within cell analysis for pharmaceutical development. Customers are found worldwide and mainly comprise researchers in pharmaceutical companies and universities.

For further information, please contact:
Henrik Joelsson, Investment Director, Ratos, +46 8 700 17 00
Peter Ehrenheim, Chairman of Biolin Scientific, +46 706 67 57 11
Johan von Heijne, incoming CEO Biolin Scientific, +46 705 95 15 10
Emma Rheborg, Head of Corporate Communications and IR, Ratos, +46 8 700 17 00